2005
DOI: 10.1007/s11926-005-0006-y
|View full text |Cite
|
Sign up to set email alerts
|

Considerations in the treatment of early osteoarthritis

Abstract: Osteoarthritis is the most common form of arthritis and it is one of the leading causes of disability in all elderly populations. It results in enormous societal burden, including the need for joint replacement at an annual cost to the community of billions of dollars. Two factors that predicate the formulation of a treatment strategy for an individual with "early" osteoarthritis include the risk for toxicity from long duration of exposure to pharmaceuticals and the desirability of a treatment with the potenti… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
2

Citation Types

0
9
0

Year Published

2009
2009
2017
2017

Publication Types

Select...
6

Relationship

0
6

Authors

Journals

citations
Cited by 11 publications
(9 citation statements)
references
References 43 publications
0
9
0
Order By: Relevance
“…The recent success of strontium ranelate as a disease-modifying agent for OA provides the first clear evidence that this hypothesis has been confirmed [40]. Some other bone-targeting agents have been assessed as OA therapeutics, including bisphosphonates [41,42], calcitonin [43] and vitamin D [44]. These bone-acting agents are unlikely to be effective in late stages of OA, when remodeling is already suppressed.…”
Section: Discussionmentioning
confidence: 99%
“…The recent success of strontium ranelate as a disease-modifying agent for OA provides the first clear evidence that this hypothesis has been confirmed [40]. Some other bone-targeting agents have been assessed as OA therapeutics, including bisphosphonates [41,42], calcitonin [43] and vitamin D [44]. These bone-acting agents are unlikely to be effective in late stages of OA, when remodeling is already suppressed.…”
Section: Discussionmentioning
confidence: 99%
“…4 The same authors have postulated a protective mechanism of vitamin D against knee osteoarthritis, due to increased nitric oxide synthesis. 8 The possible protective effect of vitamin D on knee osteoarthritis progression has led to a recommendation for vitamin D supplementation in the treatment of early knee osteoarthritis, 6 particularly in patients with low bone mineral density. 14 However, while vitamin D levels are commonly low in knee osteoarthritis patients, there is not a linear correlation between these levels and osteoarthritis grade or functional incapacitation.…”
Section: Discussionmentioning
confidence: 99%
“…5 It has been suggested that vitamin D supplementation should be included in the treatment algorithm of early knee osteoarthritis, as it might be preferable to long-term anti-inflammatory intake. 6 Vitamin D supplementation appears to be important in improving prognosis of both osteoporosis and osteoarthritis according to some reports. 7 The current cohort evaluation was performed in order to assess whether the evaluation of vitamin D levels is imperative in the evaluation of patients with severe knee osteoarthritis in an Israeli population.…”
Section: Introductionmentioning
confidence: 99%
“…Among various reasons, these knee disorders are attributed to obesity-related problems among the population. Knee replacement or knee arthroplasty is a procedure for treating osteoarthritis by replacing the worn cartilage between the knee joints with an artificial implant component (Arabelovic & McAlindon, 2005;Harman et al, 2014). This method has been proven to effectively relieve pain and regain normal knee movement in patients suffering from this disorder.…”
Section: Introductionmentioning
confidence: 99%